MAY 2021
AMERICAN SOCIETY OF HEMATOLOGY HEADQUARTERS 2021 L Street NW , Suite 900 Washington , DC 20036 www . hematology . org Tel : 202-776-0544
CONTENTS
EDITOR-IN-CHIEF Aaron Gerds , MD
Cleveland Clinic Cleveland , OH
ASSOCIATE EDITORS Elizabeth Brém , MD UC Irvine Medical Center Orange , CA
Aristoteles Giagounidis , MD Marien Hospital Düsseldorf , Germany
Sandra Kurtin , PhD The University of Arizona Tucson , AZ
Joseph Mikhael , MD , MEd
City of Hope Cancer Center Phoenix , AZ
Bethany Samuelson Bannow , MD Oregon Health & Science University Portland , OR
Alexandra Wolanskyj-Spinner , MD
Mayo Clinic Rochester , MN
PUBLISHER American Medical Communications
EDITORIAL
MANAGING EDITORS Kristin Hubing , ASH Ariel Jones-DeMaio , AMC
EDITORIAL COORDINATOR Sabrina Ahle , AMC
ART DIRECTOR Ari Mihos
ASSISTANT ART DIRECTORS Charlene DePrizio John Salesi
DIGITAL PROJECTS MANAGER Chris Gedikli
FEATURES
Cellular Therapies Hold Promise in Myeloid Malignancies There is hope that these therapies will improve outcomes , but development is still in early stages .
s2
Four of a Kind ? Soon , there may be as many as four JAK inhibitors available for patients with myelofibrosis
s4
IN THE LITERATURE
Next-Generation Karyotyping Outperforms Conventional Cytogenetics for Prognostication of AML s6
Universal CAR T-Cell Platform Shows Promising Efficacy in Relapsed / Refractory AML s7
ADVERTISING
ACCOUNT MANAGERS Nick Luciano NLuciano @ AMCmediagroup . com
Kim Silverman KSilverman @ AMCmediagroup . com
Phil Soufleris PSoufleris @ AMCmediagroup . com
Recruitment advertising orders can be sent to : DIRECTOR , RECRUITMENT CLASSIFIEDS Lauren Morgan
LMorgan @ AMCmediagroup . com 1 Focus on Myeloid Malignancies
ONLINE
Check out our “ Topic Compilation ” on myeloid malignancies at ASHClinicalNews . org , with recent stories like :
• Is Pretransplant Disease Reduction Necessary in MDS and AML ?
• Daunorubicin and Cytarabine Combination Approved for Pediatric Secondary AML
• How Do Patients With Myeloproliferative Neoplasms Fare After COVID-19 Infection ?
• HLA-Haploidentical Relative and Matched Unrelated Donor Transplant Lead to Similar Survival Outcomes in MDS
Make sure to follow @ ASHClinicalNews for the latest updates in hematology !
© 2021 by the American Society of Hematology . All materials contained in this newsletter are protected by copyright laws and may not be used , reproduced , or otherwise exploited in any manner without the express prior written permission of ASH Clinical News . Any third-party materials communicated to ASH Clinical News become its copyrighted property and may be used , reproduced , or otherwise exploited by ASH Clinical News .
All correspondence for the American Society of Hematology should be sent to : American Society of Hematology , 2021 L Street NW , Suite 900 , Washington DC 20036 .
Neither the American Society of Hematology nor the publisher is responsible for statements made by any editor or contributor . Statements , editorials , or opinions expressed in ASH Clinical News magazine do not necessarily represent official policy of the American Society of Hematology unless so stated . No responsibility is assumed by the American Society of Hematology or the Publisher for any injury or damage to persons or property as a matter of product liability , negligence or otherwise or from any use or operation of any methods , products , instructions or ideas contained in the material herein .
Although all advertising material published in ASH Clinical News magazine is expected to conform to ethical ( medical ) standards , inclusion in this publication does not constitute a guarantee or endorsement by the American Society of Hematology or the Publisher of the quality or value of such product or of the claim made of it by its manufacturer .
About the American Society of Hematology The American Society of Hematology ( ASH ) is the world ’ s largest professional society concerned with the causes and treatments of blood disorders . The mission of the Society is to further the understanding , diagnosis , treatment , and prevention of disorders affecting the blood , bone marrow , and the immunologic , hemostatic and vascular systems , by promoting research , clinical care , education , training , and advocacy in hematology .
ASHClinicalNews . org ASH Clinical News s1